Jacob J. Swidorski - Concepedia

Author

Jacob J. Swidorski

Bristol-Myers Squibb (United States)ORCID

Also Known As

J. Swidorski, Jacob J. Swidorski, Jacob Swidorski, Swidorski, J.J., Swidorski, Jacob J.

Publications

628

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Wisconsin–Madison University of Minnesota Bristol-Myers Squibb (India)

About

Jacob J. Swidorski is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, natural sciences, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	294
2	Natural Sciences	8	8	255
3	Biochemistry	6	6	153
4	Biomolecular Engineering	4	4	181
5	Engineering	3	3	127

Jacob J. Swidorski

Publications

571

Citations

H-Index

Page 1

	Year	Citations
Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage Beata Nowicka-Sans, Tricia Protack, Zeyu Lin, Antimicrobial Agents and Chemotherapy Microbial PathogensImmunologyMolecular BiologyImmunodominanceAntiviral Drug	2016	65
A Lewis Acid-Catalyzed Formal [3 + 3] Cycloaddition of α,β-Unsaturated Aldehydes with 4-Hydroxy-2-Pyrone, Diketones, and Vinylogous Esters Aleksey V. Kurdyumov, Nan Lin, Richard P. Hsung, Organic Letters	2005	59
An Efficient Assembly of Heterobenzazepine Ring Systems Utilizing an Intramolecular Palladium-Catalyzed Cycloamination Brandon J. Margolis, Jacob J. Swidorski, Bruce N. Rogers The Journal of Organic Chemistry Combinatorial ChemistryEngineeringOrganic ChemistryChemistryHeterocycle Chemistry	2002	56
Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity Alicia Regueiro‐Ren, Zheng Liu, Yan Chen, ACS Medicinal Chemistry Letters Medicinal ChemistryTranslational MedicineGood Oral ExposureMedicineHuman Retrovirus	2016	54
A Concise Total Synthesis of (−)-Cylindricine C through a Stereoselective Intramolecular <i>Aza</i>-[3 + 3] Annulation Strategy Jacob J. Swidorski, Jiashi Wang, Richard P. Hsung Organic Letters	2006	53
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 12. Structure–Activity Relationships Associated with 4-Fluoro-6-azaindole Derivatives Leading to the Identification of 1-(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-585248) Alicia Regueiro‐Ren, Qiufen Xue, Jacob J. Swidorski, Journal of Medicinal Chemistry Vitro PotencyGood PotencyAzaindole CoreAntiviral DrugChemical Biology	2013	50
An <i>N</i>-Acyliminium Cyclization Approach to a Total Synthesis of (+)-Cylindricine C Jia Liu, Jacob J. Swidorski, Scott Peters, The Journal of Organic Chemistry Seldom-used Wharton RearrangementNovel OrganocatalystsEngineeringTotal SynthesisOrganic Chemistry	2005	47
Inhibitors of HIV-1 maturation: Development of structure–activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids Jacob J. Swidorski, Zheng Liu, Sing‐Yuen Sit, Bioorganic & Medicinal Chemistry Letters Structure–activity RelationshipHiv-1 MaturationMedicinal ChemistryMedicineNatural Sciences	2016	35
Inhibitors of HIV-1 attachment: The discovery and structure–activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore Jacob J. Swidorski, Zheng Liu, Zhiwei Yin, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryBiochemistryMedicine	2015	30
C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors Zheng Liu, Jacob J. Swidorski, Beata Nowicka-Sans, Bioorganic & Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryBiochemistryMedicine	2016	28

Page 1